The market for vitamin D therapy is expected to grow at a CAGR of around 11.9% from 2020 to 2027 and expected to reach the market value of around US$ 3,819.4 Mn by 2027.
Vitamin D is a group of fat-soluble secosteroids, which aids in the intestinal absorption of calcium, magnesium, and phosphate, and many other biological elements. It helps in forming and maintaining strong bones; additionally, the intake of fat-soluble vitamin may provide protection and decrease the risk of developing osteoporosis, hypertension, cancer, and several autoimmune diseases. About 90% of the required vitamin D is synthesized in the skin under sun exposure. Vitamin D can also help in regulating mood, as many studies have also shown that low vitamin D was linked to higher level of depression and anxiety. Moreover, lack of vitamin D leads to the bone deformities such as rickets in children, and bone pain caused by a condition called osteomalacia in adults. In addition, vitamin D therapy helps in combating the risks associated with deficiency of vitamin D produced naturally in the body.
Market Dynamics
The growing awareness about vitamin D deficiency among consumers across the globe is primarily driving the market growth. The presence of a large target patient population due to lack of vitamin D intake is additionally supporting the market growth. Some of the factors driving the market growth include changing food habits contributing to low dietary calcium and Vitamin D intake, increased indoor lifestyle, thereby preventing adequate exposure to sunlight, increasing pollution hampering the synthesis of vitamin D in the skin by UV rays, increased skin pigmentation and application of sunscreens, cultural practices such as the burqa and purdah system, unspaced and unplanned pregnancies in women with dietary deficit leading to worsening of vitamin D status in both mother and child. Furthermore, countries with a high prevalence of malnourished as well as developing economies are expected to create potential growth opportunities over the forecast period from 2020 to 2027.
Segment Instance of Global Vitamin D Therapy Market
Oral route of administration is leading the Vitamin D therapy market
In 2019, the oral route of administration lead the market with maximum revenue share and the segment is also projected to maintain its dominance over the forecast period from 2020 to 2027. The advantages associated with the oral route like ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity and increased patient compliance are supporting the segmental market value.
North America dominated the Vitamin D Therapy Market in 2019
The major economies of North America including the US and Canada are contributing to the regional market value. The well-established healthcare infrastructure, high disposable income, and aware population base are supporting the regional market value. Additionally, the presence of major players in the region is another factor propelling the regional market value.
Asia Pacific is anticipated to exhibit fastest growth over the forecast period from 2020 to 2027
The Asia Pacific is estimated to experience the fastest growth during the forecast period from 2020 to 2027. The increasing demand in vitamin D supplements due to the presence of a large population base is supporting the regional market growth. The rising awareness about vitamin D deficiency, increasing lifestyle diseases, rising expenditure in the healthcare sector are some of the factors driving the market growth.
Key Players Profiled
The players profiled in the report include Abbott Laboratories, Alkem Laboratories Ltd., Cadila Healthcare Ltd., GlaxoSmithKline PLC, Merck & Co., Inc., Novartis AG, Pfizer Inc, Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Torrent Pharmaceuticals Ltd. among others.
Market Segmentation
Market By Route of Administration
Oral
Parenteral
Market By Purchasing Patterns
Prescription
Over-The-Counter
Market By Application
Osteoporosis
Rickets
Skin Diseases
Muscle Weakness
Autoimmune Disorders
Other Applications
Market By Geography
North America
• U.S.
• Canada
Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Vitamin D Therapy
1.1. Definition and Scope
1.1.1. Definition of Vitamin D Therapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Vitamin D Therapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Vitamin D Therapy Market By Route of Administration
1.2.3. Vitamin D Therapy Market By Purchasing Patterns
1.2.4. Vitamin D Therapy Market By Application
1.2.5. Vitamin D Therapy Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Vitamin D Therapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Vitamin D Therapy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Vitamin D Therapy Major Manufacturers in 2019
CHAPTER 5. Vitamin D Therapy Market By Route of Administration
5.1. Introduction
5.2. Vitamin D Therapy Revenue By Route of Administration
5.2.1. Vitamin D Therapy Revenue (US$ Mn) and Forecast, By Route of Administration, 2016-2027
5.2.2. Oral
5.2.2.1. Oral Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Parenteral
5.2.3.1. Parenteral Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Vitamin D Therapy Market Revenue By Purchasing Patterns
6.1. Introduction
6.2. Vitamin D Therapy Revenue (US$ Mn) By Purchasing Patterns
6.2.1. Vitamin D Therapy Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
6.2.2. Prescription
6.2.2.1. Prescription Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Over-The-Counter
6.2.3.1. Over-The-Counter Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Vitamin D Therapy Market By Application
7.1. Introduction
7.2. Vitamin D Therapy Revenue (US$ Mn) By Application
7.2.1. Vitamin D Therapy Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
7.2.2. Osteoporosis
7.2.2.1. Osteoporosis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Rickets
7.2.3.1. Rickets Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Skin Diseases
7.2.4.1. Skin Diseases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.5. Muscle Weakness
7.2.5.1. Muscle Weakness Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.6. Others Autoimmune Disorders
7.2.6.1. Others Autoimmune Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.7. Others
7.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Vitamin D Therapy Market By Country
8.1. North America Vitamin D Therapy Overview
8.2. U.S.
8.2.1. U.S. Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.2.2. U.S. Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016-2027
8.2.3. U.S. Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3. Canada
8.3.1. Canada Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.3.2. Canada Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016-2027
8.3.3. Canada Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Vitamin D Therapy Market By Country
9.1. Europe Vitamin D Therapy Market Overview
9.2. U.K.
9.2.1. U.K. Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.2.2. U.K. Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016-2027
9.2.3. U.K. Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.3. Germany
9.3.1. Germany Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.3.2. Germany Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016-2027
9.3.3. Germany Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.4. France
9.4.1. France Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.4.2. France Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016-2027
9.4.3. France Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.5. Spain
9.5.1. Spain Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.5.2. Spain Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016-2027
9.5.3. Spain Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.6.2. Rest of Europe Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016-2027
9.6.3. Rest of Europe Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Vitamin D Therapy Market By Country
10.1. Asia Pacific Vitamin D Therapy Market Overview
10.2. China
10.2.1. China Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.2.2. China Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
10.2.3. China Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3. Japan
10.3.1. Japan Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.3.2. Japan Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
10.3.3. Japan Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4. India
10.4.1. India Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.4.2. India Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
10.4.3. India Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.5. Australia
10.5.1. Australia Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.5.2. Australia Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
10.5.3. Australia Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.6.2. South Korea Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
10.6.3. South Korea Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.7.2. Rest of Asia-Pacific Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
10.7.3. Rest of Asia-Pacific Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Vitamin D Therapy Market By Country
11.1. Latin America Vitamin D Therapy Market Overview
11.2. Brazil
11.2.1. Brazil Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.2.2. Brazil Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
11.2.3. Brazil Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.3.2. Mexico Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
11.3.3. Mexico Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.4.2. Rest of Latin America Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
11.4.3. Rest of Latin America Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
CHAPTER 12. Middle East & Africa Vitamin D Therapy Market By Country
12.1. Middle East & Africa Vitamin D Therapy Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.2.2. Saudi Arabia Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
12.2.3. Saudi Arabia Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.3. UAE
12.3.1. UAE Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.3.2. UAE Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
12.3.3. UAE Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.4.2. Rest of Middle East & Africa Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Purchasing Patterns, 2016 - 2027
12.4.3. Rest of Middle East & Africa Vitamin D Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
CHAPTER 13. Player Analysis Of Vitamin D Therapy
13.1. Vitamin D Therapy Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Vitamin D Therapy Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. COMPANY PROFILE
14.1. Abbott Laboratories
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Abbott Laboratories 2019 Vitamin D Therapy Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Alkem Laboratories Ltd.
14.3. Cadila Healthcare Ltd.
14.4. GlaxoSmithKline PLC
14.5. Merck & Co., Inc.
14.6. Novartis AG
14.7. Pfizer Inc
14.8. Sanofi S.A.
14.9. Sun Pharmaceutical Industries Ltd.
14.10. Torrent Pharmaceuticals Ltd.
14.11. Others
